Cited 7 time in
Off-label use of plastic syringes with silicone oil for intravenous infusion bags of antibodies
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Nam Ah | - |
| dc.contributor.author | Hada, Shavron | - |
| dc.contributor.author | Kim, Dong Jun | - |
| dc.contributor.author | Choi, Du Hyung | - |
| dc.contributor.author | Jeong, Seong Hoon | - |
| dc.date.accessioned | 2024-08-08T09:31:28Z | - |
| dc.date.available | 2024-08-08T09:31:28Z | - |
| dc.date.issued | 2021-09 | - |
| dc.identifier.issn | 0939-6411 | - |
| dc.identifier.issn | 1873-3441 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/20916 | - |
| dc.description.abstract | The formation of particulates in post-manufacture biopharmaceuticals continues to be a major concern in medical treatment. This study was designed to evaluate the content of micro-sized particles using flow imaging of antibodies in intravenous infusion bags. Intravenous immunoglobulin (IVIG) and Avastin (R) were selected as model drugs and plastic syringes with and without silicone oil (SO) were used to transfer the drugs into the bags (0.9% saline or 5% dextrose). Antibodies exposed to SO had significantly increased levels of microparticles in both diluents, suggesting SO accelerates particle formation, especially at a higher antibody concentration. Even before the drop stress, their count exceeded the USP guideline. Dropping the bags in the presence of SO produced larger microparticles. Meanwhile, air bubbles were retained longer in saline suggesting more protein film formation on its air-water interface. Overall, both drugs were conformationally stable and produced less particles in dextrose than in saline. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER | - |
| dc.title | Off-label use of plastic syringes with silicone oil for intravenous infusion bags of antibodies | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.ejpb.2021.07.001 | - |
| dc.identifier.scopusid | 2-s2.0-85109462531 | - |
| dc.identifier.wosid | 000676615700003 | - |
| dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v.166, pp 205 - 215 | - |
| dc.citation.title | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | - |
| dc.citation.volume | 166 | - |
| dc.citation.startPage | 205 | - |
| dc.citation.endPage | 215 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | AGITATION-INDUCED AGGREGATION | - |
| dc.subject.keywordPlus | MONOCLONAL-ANTIBODY | - |
| dc.subject.keywordPlus | SUBVISIBLE PARTICLES | - |
| dc.subject.keywordPlus | PROTEIN AGGREGATION | - |
| dc.subject.keywordPlus | COLLOIDAL STABILITY | - |
| dc.subject.keywordPlus | IONIC-STRENGTH | - |
| dc.subject.keywordPlus | HUMAN PLASMA | - |
| dc.subject.keywordPlus | IMMUNOGENICITY | - |
| dc.subject.keywordPlus | FORMULATIONS | - |
| dc.subject.keywordPlus | SURFACE | - |
| dc.subject.keywordAuthor | Subvisible particle | - |
| dc.subject.keywordAuthor | Silicone oil | - |
| dc.subject.keywordAuthor | IV infusion | - |
| dc.subject.keywordAuthor | IVIG | - |
| dc.subject.keywordAuthor | Avastin (R) | - |
| dc.subject.keywordAuthor | Flow imaging | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
